Novel use of acitretin for posttransplant Grover’s disease and cutaneous graft versus host disease
Year: 2023
Type: article
Study design: Case Report
Abstract: Retinoids have been reported to be efficacious in patients with sclerodermatous chronic graft-versus-host disease (cGVHD) and enhance T-regulatory cells in GVHD mouse models.1,2 However, to our knowledge, there is no literature supporting acitretin as treatment for superficial forms of cutaneous cGVHD. We present a case of extensive Grover’s disease and superficial cutaneous cGVHD treated successfully with acitretin.
Source: JAAD Case Reports
Authors: Neha Gupta, Cesar A. Virgen, Amrita Goyal, Andrew A. Lane, Joseph H. Antin, Sherrie J. Divito, Cecilia Larocca
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $675
OpenAlex ID: W4318323669